Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone acetate acceptors with levonorgestrel implants fo...
Saved in:
Main Authors: | Irwan Daido (Author), Andi M Tahir (Author), St Maisuri T Chalid (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Society of Obstetrics and Gynecology,
2014-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Risk of Infection Human Papilloma Virus Infection in Acceptors of Depot Medroxyprogesterone Acetate Contraceptions
by: Baharuddin Aras, et al.
Published: (2018) -
Effects of Depot Medroxyprogesterone Acetate Intramuscular Injection, Copper Intrauterine Device and Levonorgestrel Implant Contraception on Estradiol Levels: An Ancillary Study of the ECHO Randomized Trial
by: Rebecca Ryan, et al.
Published: (2022) -
Effect of depot-medroxyprogesterone acetate injections on serum immunoglobulins and complements level
by: Wahda B. Al-Youzbaki
Published: (2008) -
Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
by: Douglas J. Taylor, et al.
Published: (2022) -
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
by: Lam C, et al.
Published: (2016)